These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16996476)

  • 1. Silencing of vanilloid receptor TRPV1 by RNAi reduces neuropathic and visceral pain in vivo.
    Christoph T; Grünweller A; Mika J; Schäfer MK; Wade EJ; Weihe E; Erdmann VA; Frank R; Gillen C; Kurreck J
    Biochem Biophys Res Commun; 2006 Nov; 350(1):238-43. PubMed ID: 16996476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats.
    Kanai Y; Nakazato E; Fujiuchi A; Hara T; Imai A
    Neuropharmacology; 2005 Dec; 49(7):977-84. PubMed ID: 15998524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
    J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of antisense oligonucleotides against the vanilloid receptor VR1/TRPV1.
    Christoph T; Gillen C; Mika J; Grünweller A; Schäfer MK; Schiene K; Frank R; Jostock R; Bahrenberg G; Weihe E; Erdmann VA; Kurreck J
    Neurochem Int; 2007 Jan; 50(1):281-90. PubMed ID: 17045702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia.
    Honore P; Chandran P; Hernandez G; Gauvin DM; Mikusa JP; Zhong C; Joshi SK; Ghilardi JR; Sevcik MA; Fryer RM; Segreti JA; Banfor PN; Marsh K; Neelands T; Bayburt E; Daanen JF; Gomtsyan A; Lee CH; Kort ME; Reilly RM; Surowy CS; Kym PR; Mantyh PW; Sullivan JP; Jarvis MF; Faltynek CR
    Pain; 2009 Mar; 142(1-2):27-35. PubMed ID: 19135797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.
    Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ
    Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
    Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
    Knotkova H; Pappagallo M; Szallasi A
    Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice.
    Christoph T; Bahrenberg G; De Vry J; Englberger W; Erdmann VA; Frech M; Kögel B; Röhl T; Schiene K; Schröder W; Seibler J; Kurreck J
    Mol Cell Neurosci; 2008 Mar; 37(3):579-89. PubMed ID: 18249134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.
    Vos MH; Neelands TR; McDonald HA; Choi W; Kroeger PE; Puttfarcken PS; Faltynek CR; Moreland RB; Han P
    J Neurochem; 2006 Nov; 99(4):1088-102. PubMed ID: 17018028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain.
    Endres-Becker J; Heppenstall PA; Mousa SA; Labuz D; Oksche A; Schäfer M; Stein C; Zöllner C
    Mol Pharmacol; 2007 Jan; 71(1):12-8. PubMed ID: 17005903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role for TRPV1 in neomycin-induced inhibition of visceral hypersensitivity in rat.
    van den Wijngaard RM; Welting O; Bulmer DC; Wouters MM; Lee K; de Jonge WJ; Boeckxstaens GE
    Neurogastroenterol Motil; 2009 Aug; 21(8):863-e60. PubMed ID: 19298229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats.
    Winston J; Shenoy M; Medley D; Naniwadekar A; Pasricha PJ
    Gastroenterology; 2007 Feb; 132(2):615-27. PubMed ID: 17258716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat.
    Kasama S; Kawakubo M; Suzuki T; Nishizawa T; Ishida A; Nakayama J
    Eur J Neurosci; 2007 May; 25(10):2956-63. PubMed ID: 17509082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.